{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:00:05Z","timestamp":1783198805234,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4031454"],"award-info":[{"award-number":["4031454"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05129-w","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:18:49Z","timestamp":1760519929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nano-curcumin potentiates antitumor immunity in prostate cancer via co-culture with adipose-derived mesenchymal stem cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Farid","family":"Zeynali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika Hadad","family":"Tehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh Sadat","family":"Tabasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevda","family":"Ghoreyshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh Lavi","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"5129_CR1","doi-asserted-by":"publisher","unstructured":"Wang S, Zhang F, Chen J. Application and potential value of Curcumin in prostate cancer: a meta-analysis based on animal models. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1379389.","DOI":"10.3389\/fphar.2024.1379389"},{"key":"5129_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10111536","volume":"10","author":"D Termini","year":"2020","unstructured":"Termini D, Den Hartogh DJ, Jaglanian A, Tsiani E. Curcumin against prostate cancer: current evidence. Biomolecules. 2020;10:1\u201340. https:\/\/doi.org\/10.3390\/biom10111536.","journal-title":"Biomolecules"},{"key":"5129_CR3","doi-asserted-by":"publisher","first-page":"052008","DOI":"10.1088\/1748-605X\/acf0af","volume":"18","author":"C Ratan","year":"2023","unstructured":"Ratan C, Arian AM, Rajendran R, Jayakumar R, Masson M, Mangalathillam S. Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer. Biomed Mater. 2023;18:052008. https:\/\/doi.org\/10.1088\/1748-605X\/acf0af.","journal-title":"Biomed Mater"},{"key":"5129_CR4","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3390\/pharmaceutics15092223","volume":"15","author":"D Mundekkad","year":"2023","unstructured":"Mundekkad D, Cho WC. Applications of curcumin and its nanoforms in the treatment of cancer. Pharmaceutics. 2023;15:2223. https:\/\/doi.org\/10.3390\/pharmaceutics15092223.","journal-title":"Pharmaceutics"},{"issue":"1","key":"5129_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01272-x","volume":"15","author":"M Boroughani","year":"2024","unstructured":"Boroughani M, Moaveni AK, Hatami P, Mansoob Abasi N, Seyedoshohadaei SA, Pooladi A, et al. Nanocurcumin in cancer treatment: a comprehensive systematic review. Discover Oncol. 2024;15(1):515. https:\/\/doi.org\/10.1007\/s12672-024-01272-x.","journal-title":"Discover Oncol"},{"key":"5129_CR6","doi-asserted-by":"publisher","unstructured":"Allegra A, Mirabile G, Ettari R, Pioggia G, Gangemi S. The impact of Curcumin on immune response: an Immunomodulatory strategy to treat sepsis. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232314710.","DOI":"10.3390\/ijms232314710"},{"key":"5129_CR7","doi-asserted-by":"publisher","unstructured":"Bertoncini-Silva C, Vlad A, Ricciarelli R, Giacomo Fassini P, Suen VMM, Zingg JM. Enhancing the bioavailability and bioactivity of Curcumin for disease prevention and treatment. Antioxidants 2024;13. https:\/\/doi.org\/10.3390\/antiox13030331","DOI":"10.3390\/antiox13030331"},{"key":"5129_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejpb.2021.02.010","volume":"161","author":"S Patnaik","year":"2021","unstructured":"Patnaik S, Gorain B, Padhi S, Choudhury H, Gabr GA, Md S, et al. Recent update of toxicity aspects of nanoparticulate systems for drug delivery. Eur J Pharm Biopharm. 2021;161:100\u201319. https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.010.","journal-title":"Eur J Pharm Biopharm"},{"key":"5129_CR9","doi-asserted-by":"publisher","unstructured":"Heo JS, Choi Y, Kim HO, Matta C. Adipose-Derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes. Stem Cells Int 2019;2019. https:\/\/doi.org\/10.1155\/2019\/7921760","DOI":"10.1155\/2019\/7921760"},{"key":"5129_CR10","doi-asserted-by":"publisher","unstructured":"Wang L, Jiang X, Zhao F, Duan P, Li Z, Luo Y. A review of adipose-derived mesenchymal stem cells\u2018 impacts and challenges: metabolic regulation, tumor modulation, immunomodulation, regenerative medicine and genetic engineering therapies. Front Endocrinol (Lausanne). 2025;16. https:\/\/doi.org\/10.3389\/fendo.2025.1606847.","DOI":"10.3389\/fendo.2025.1606847"},{"key":"5129_CR11","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1002\/stem.136","volume":"27","author":"LATA G MENON","year":"2009","unstructured":"MENON LATA G. Human Bone Marrow-Derived Mesenchymal Stromal Cells Expressing S-TRAIL as a Cellular Delivery Vehicle for Human Glioma Therapy\u2020\u2021. Stem Cells. 2009;27:2320\u201330. https:\/\/doi.org\/10.1002\/stem.136.","journal-title":"Stem Cells"},{"key":"5129_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2009.08.031","volume":"290","author":"P Gao","year":"2010","unstructured":"Gao P, Ding Q, Wu Z, Jiang H, Fang Z. Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett. 2010;290:157\u201366. https:\/\/doi.org\/10.1016\/j.canlet.2009.08.031.","journal-title":"Cancer Lett"},{"key":"5129_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.111011","volume":"115","author":"J Wu","year":"2024","unstructured":"Wu J, Ji H, Li T, Guo H, Xu H, Zhu J, et al. Targeting the prostate tumor microenvironment by plant-derived natural products. Cell Signal. 2024;115:111011. https:\/\/doi.org\/10.1016\/j.cellsig.2023.111011.","journal-title":"Cell Signal"},{"key":"5129_CR14","doi-asserted-by":"publisher","unstructured":"Ceccarelli S, Pontecorvi P, Anastasiadou E, Napoli C, Marchese C. Immunomodulatory effect of Adipose-Derived stem cells: the cutting edge of clinical application. Front Cell Dev Biol. 2020;8. https:\/\/doi.org\/10.3389\/fcell.2020.00236.","DOI":"10.3389\/fcell.2020.00236"},{"key":"5129_CR15","doi-asserted-by":"publisher","unstructured":"Boroughani M, Moaveni AK, Hatami P, Mansoob Abasi N, Seyedoshohadaei SA, Pooladi A et al. Nanocurcumin in cancer treatment: a comprehensive systematic review. Discover Oncol 2024;15. https:\/\/doi.org\/10.1007\/s12672-024-01272-x","DOI":"10.1007\/s12672-024-01272-x"},{"key":"5129_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s13311-018-0606-7","volume":"15","author":"M Ahmadi","year":"2018","unstructured":"Ahmadi M, Agah E, Nafissi S, Jaafari MR, Harirchian MH, Sarraf P, et al. Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics. 2018;15:430\u20138. https:\/\/doi.org\/10.1007\/s13311-018-0606-7.","journal-title":"Neurotherapeutics"},{"key":"5129_CR17","unstructured":"Rahimi HR, Hooshang Mohammadpour A, Dastani M, Jaafari MR, Abnous K, Mobarhan MG et al. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna journal of Phytomedicine. 2016;6(5):567\u201377 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5052420"},{"key":"5129_CR18","doi-asserted-by":"publisher","unstructured":"Tehran MH, Arab FL, Zeynali F, Mahmoudi M, Tabasi NS, Khayatzadeh J. The effects of Crocin and Crocetin on immune cells of prostate cancer patients in co-culture with adipose-derived mesenchymal stem cells. J Funct Foods. 2024;121. https:\/\/doi.org\/10.1016\/j.jff.2024.106406.","DOI":"10.1016\/j.jff.2024.106406"},{"key":"5129_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jcb.29826","volume":"122","author":"F Yousefi","year":"2021","unstructured":"Yousefi F, Arab FL, Rastin M, Tabasi NS, Nikkhah K, Mahmoudi M. Comparative assessment of immunomodulatory, proliferative, and antioxidant activities of Crocin and Crocetin on mesenchymal stem cells. J Cell Biochem. 2021;122:29\u201342. https:\/\/doi.org\/10.1002\/jcb.29826.","journal-title":"J Cell Biochem"},{"key":"5129_CR20","doi-asserted-by":"publisher","unstructured":"Lavi Arab F, Yousefi F, Reza Jaafari M, Rajabian A, Dana H, Tabasi N, et al. Evaluation of the immune-modulatory, anti-oxidant, proliferative, and anti-apoptotic effects of nano-silymarin on mesenchymal stem cells isolated from multiple sclerosis patients\u2019 adipose tissue sources. J Funct Foods. 2024;113. https:\/\/doi.org\/10.1016\/j.jff.2023.105958.","DOI":"10.1016\/j.jff.2023.105958"},{"key":"5129_CR21","doi-asserted-by":"publisher","unstructured":"Hewlings SJ, Kalman DS. Curcumin: A review of its effects on human health. Foods. 2017;6. https:\/\/doi.org\/10.3390\/foods6100092.","DOI":"10.3390\/foods6100092"},{"key":"5129_CR22","doi-asserted-by":"publisher","unstructured":"Guo Y, Su J, Jiang S, Xu Y, Dou B, Li T, et al. Transcriptomics and metabonomics study on the effect of exercise combined with Curcumin supplementation on breast cancer in mice. Heliyon. 2024;10. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28807.","DOI":"10.1016\/j.heliyon.2024.e28807"},{"key":"5129_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.intimp.2011.04.002","volume":"11","author":"F Luo","year":"2011","unstructured":"Luo F, Song X, Zhang Y, Chu Y. Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity. Int Immunopharmacol. 2011;11:1234\u201340. https:\/\/doi.org\/10.1016\/j.intimp.2011.04.002.","journal-title":"Int Immunopharmacol"},{"key":"5129_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cdp.2005.05.003","volume":"29","author":"S Pal","year":"2005","unstructured":"Pal S, Bhattacharyya S, Choudhuri T, Datta GK, Das T, Sa G. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detect Prev. 2005;29:470\u20138. https:\/\/doi.org\/10.1016\/j.cdp.2005.05.003.","journal-title":"Cancer Detect Prev"},{"key":"5129_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13008-015-0012-z","volume":"10","author":"S Bose","year":"2015","unstructured":"Bose S, Panda AK, Mukherjee S, Sa G. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div. 2015;10:6. https:\/\/doi.org\/10.1186\/s13008-015-0012-z.","journal-title":"Cell Div"},{"key":"5129_CR26","doi-asserted-by":"publisher","first-page":"15954","DOI":"10.1074\/jbc.M608189200","volume":"282","author":"S Bhattacharyya","year":"2007","unstructured":"Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T, Sa G. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem. 2007;282:15954\u201364. https:\/\/doi.org\/10.1074\/jbc.M608189200.","journal-title":"J Biol Chem"},{"key":"5129_CR27","doi-asserted-by":"publisher","unstructured":"Bawden EG, Wagner T, Schr\u00f6der J, Effern M, Hinze D, Newland L, Attrill GH, Lee AR, Engel S, Freestone D, de Lima Moreira M. CD4+ T cell immunity against cutaneous melanoma encompasses multifaceted MHC II\u2013dependent responses. Science immunology. 2024;9(91):eadi9517.\u00a0https:\/\/doi.org\/10.1126\/sciimmunol.adi9517.","DOI":"10.1126\/sciimmunol.adi9517"},{"key":"5129_CR28","doi-asserted-by":"publisher","unstructured":"Dey S, Sutanto-Ward E, Kopp KL, Duhadaway J, Mondal A, Ghaban D, et al. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8\u2009+\u2009and CD4\u2009+\u2009T-cell-mediated antitumor immunity and enhanced anti-PD1 responses. J Immunother Cancer. 2020;8. https:\/\/doi.org\/10.1136\/jitc-2020-000605.","DOI":"10.1136\/jitc-2020-000605"},{"key":"5129_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cmi.2010.11","volume":"7","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S, Md Sakib Hossain D, Mohanty S, Sankar Sen G, Chattopadhyay S, Banerjee S, et al. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell Mol Immunol. 2010;7:306\u201315. https:\/\/doi.org\/10.1038\/cmi.2010.11.","journal-title":"Cell Mol Immunol"},{"key":"5129_CR30","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1177\/0960327111404909","volume":"30","author":"O Ciftci","year":"2011","unstructured":"Ciftci O, Tanyildizi S, Godekmerdan A. Curcumin, myrecen and cineol modulate the percentage of lymphocyte subsets altered by 2,3,7, 8-Tetracholorodibenzo-p-dioxins (TCDD) in rats. Hum Exp Toxicol. 2011;30:1986\u201394. https:\/\/doi.org\/10.1177\/0960327111404909.","journal-title":"Hum Exp Toxicol"},{"key":"5129_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.intimp.2012.06.016","volume":"14","author":"GJ Zhao","year":"2012","unstructured":"Zhao GJ, Lu ZQ, Tang LM, Wu ZS, Wang DW, Zheng JY, et al. Curcumin inhibits suppressive capacity of naturally occurring CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells in mice in vitro. Int Immunopharmacol. 2012;14:99\u2013106. https:\/\/doi.org\/10.1016\/j.intimp.2012.06.016.","journal-title":"Int Immunopharmacol"},{"key":"5129_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.archoralbio.2018.04.015","volume":"92","author":"F Liao","year":"2018","unstructured":"Liao F, Liu L, Luo E, Hu J. Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma. Arch Oral Biol. 2018;92:32\u20137. https:\/\/doi.org\/10.1016\/j.archoralbio.2018.04.015.","journal-title":"Arch Oral Biol"},{"key":"5129_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3892\/or.2016.5291","volume":"37","author":"C Musolino","year":"2017","unstructured":"Musolino C, Allegra A, Pioggia G, Gangemi S. Immature myeloid-derived suppressor cells: a bridge between inflammation and cancer (Review). Oncol Rep. 2017;37:671\u201383. https:\/\/doi.org\/10.3892\/or.2016.5291.","journal-title":"Oncol Rep"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05129-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:18:51Z","timestamp":1760519931000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05129-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5129"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05129-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants involved in the study provided informed consent. The procedures were performed in accordance with the Declaration of Helsinki ethical principles and approved by the Ethics Committee of Mashhad University of Medical Sciences (MUMS) with code IR.MUMS.REC.1404.020.All authors agreed to participate in submitting this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}